New FDA Reform Legislation: Congress Gifts a "FDORA" for the Holidays
On December 29, 2022, President Biden signed the Consolidated Appropriations Act, 2023 (H.R. 2617), an omnibus appropriations bill to fund the U.S…
Source: lexology.com
Page 2 - Catalyst Pharms News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Catalyst Pharms. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Catalyst Pharms Today - Breaking & Trending Today
New FDA Reform Legislation: Congress Gifts A
On December 29, 2022, President Biden signed the Consolidated Appropriations Act, 2023 (H.R. 2617), an omnibus appropriations bill to fund the U.S. government for fiscal year 2023.
Source: mondaq.com
Not Quite the Titanic: The Food and Drug Omnibus Reform Act Rescues Some FDA Policy Initiatives | King & Spalding
The Food and Drug Administration (“FDA” or the “Agency”) user fee negotiations may have hit an iceberg, but it did not sink all the legislative riders that accompanied this summer’s...
Source: jdsupra.com
NORD Applauds Legislative Efforts to Restore Intent of the Orphan Drug Act
/PRNewswire/ -- The National Organization for Rare Disorders (NORD) applauds efforts of Congressional leaders to protect the Orphan Drug Act (ODA) and ensure...
Source: prnewswire.com
U.S. Sen. Baldwin, Colleagues: Introduce bipartisan legislation to preserve access to treatments for rare disease patients
WASHINGTON, D.C. – Today, U.S. Senators Tammy Baldwin (D-WI) and Bill Cassidy, M.D. (R-LA) introduced bipartisan legislation, the Retaining Access and Resto
Source: wispolitics.com